Quick View
Loading...
Dragon Pharma
Estimated Delivery: 12-26 Days (International), 3-6 Days (United States)
Return within 45 Days of purchase. Duties & taxes are non-refundable.
Buy CJC-1295 No DAC and Ipamorelin 10 mg by Dragon Pharma at XSteroids. This is the two-peptide growth hormone blend: a GHRH analogue paired with a ghrelin receptor agonist, both short-acting, in one vial. Dragon Pharma supplies it as a 10 mg lyophilized vial. This guide covers how each peptide works, why they are combined, dosage practice and what the research does and does not show.
Neither peptide is approved for human use, so the information below is educational only.
CJC-1295 without DAC is the GHRH side of the pair: a modified fragment of growth hormone-releasing hormone (1-29) that tells the pituitary to release GH. Dropping the DAC modification means it behaves like a short-acting GHRH analogue rather than the week-long CJC-1295 DAC.
Ipamorelin is the ghrelin side: a pentapeptide that acts as a selective agonist of the ghrelin / growth hormone secretagogue receptor. Combining a GHRH analogue with a ghrelin mimetic is the standard pairing in this corner of peptide research, and it is sold here as one ready-made vial.
By mimicking GHRH at the pituitary, this fragment drives GH release and downstream IGF-1 production, but its duration is measured in hours rather than days. That is the practical difference from the DAC version, and it is why protocols using it inject more often.
Ipamorelin is unusual among GH secretagogues for what it does not do. Unlike GHRP-2 and GHRP-6, it does not stimulate ACTH or cortisol secretion - it is highly selective for GH itself. Its elimination half-life is about two hours, and it was originally developed by Novo Nordisk; a phase II programme by Helsinn Therapeutics for postoperative ileus was discontinued for lack of efficacy, and the peptide has never been approved.
Because both components are short-acting, this blend is injected more frequently than the DAC variant - typically once daily, often before bed, when natural GH release peaks. The 10 mg vial contains both peptides; the split between them is fixed by the manufacturer, so the reconstitution ratio determines how many units on an insulin syringe equal a given amount.
Mix the lyophilized powder with bacteriostatic water, aiming the stream at the vial wall rather than the powder, then swirl gently instead of shaking. Label the vial with the date, keep it refrigerated, and treat a punctured multi-dose vial as usable for 28 days after the first puncture.
The rationale is that the two peptides act on different receptors. The GHRH analogue acts on the GHRH receptor on the pituitary, while ipamorelin acts on the ghrelin/GHS receptor - separate pathways that both lead to GH release, which is why the pairing is treated as complementary rather than redundant. The same logic sits behind the other combos in this catalog, such as Ipamorelin and Tesamorelin, while single-peptide options include Ipamorelin, Sermorelin and Hexarelin - all short-acting, and all dosed accordingly.
Ipamorelin's selectivity is the reassuring part of its profile: not raising ACTH or cortisol separates it from older secretagogues. What is not available is an approved product or a long-term human safety dataset. Never-approved peptides sold for research use carry the usual unknowns, including the fact that the blend itself has not been studied as a combination, and that GH-secretagogue use in sport is restricted under anti-doping rules.
Store the lyophilized vial in a cool, dry place away from direct light before reconstitution. After mixing with bacteriostatic water, keep the solution refrigerated and use it within the recommended period for peptide solutions. Keep vials out of the reach of children.
At XSteroids you buy the Dragon Pharma CJC-1295 No DAC and Ipamorelin blend directly from the brand catalog, with secure checkout, US domestic shipping in 3 to 6 days and international delivery in 12 to 26 days. Browse the full range on the Dragon Pharma brand page to complete your research protocol.
It is a two-peptide blend in one vial. CJC-1295 without DAC is a short-acting GHRH analogue, and ipamorelin is a selective ghrelin receptor agonist that raises growth hormone. Dragon Pharma supplies it as a 10 mg lyophilized vial for research use.
The two peptides act on different receptors: the GHRH analogue stimulates the GHRH receptor on the pituitary, while ipamorelin acts on the ghrelin or GHS receptor. Both paths lead to growth hormone release, which is why they are paired rather than chosen between.
Because both peptides are short-acting, the blend is typically injected once daily, often before sleep when natural GH release peaks. The 10 mg vial sets the ratio, and the reconstitution volume determines how many units on a syringe equal a dose.
The DAC version carries an albumin-binding complex, giving it a half-life of six to eight days and weekly dosing. Without DAC, the fragment lasts hours, so it is injected daily and is often combined with a separate secretagogue such as ipamorelin.
Ipamorelin is notable for not stimulating ACTH or cortisol, unlike GHRP-2 and GHRP-6, so it is selective for GH. There is still no approved product or long-term human safety data, which is why blood work and caution still apply here.
They work on separate receptors - GHRH and ghrelin - so their effects are complementary rather than duplicative. The pairing is standard in peptide research, and it is also available alongside a longer-acting option in the Ipamorelin and Tesamorelin blend as well.
You can buy the CJC-1295 No DAC and Ipamorelin 10 mg vial by Dragon Pharma online at XSteroids. The store offers secure checkout, US domestic shipping in 3 to 6 days and international delivery in 12 to 26 days. Add the vial to your cart on this page.
Loading...
Your cart is currently empty. Let us assist you in finding the right product